These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 16380894

  • 1. [Prevention of heterotopic ossification after THA with indomethacin: analysis of risk factors].
    Zehetgruber H, Grübl A, Goll A, Schwameis E, Wurnig C, Giurea A.
    Z Orthop Ihre Grenzgeb; 2005; 143(6):631-7. PubMed ID: 16380894
    [Abstract] [Full Text] [Related]

  • 2. Short term prophylaxis against heterotopic bone after cementless hip replacement.
    Wurnig C, Auersperg V, Boehler N, Steindl M, Kiss H, Zweymuller K, Kotz R.
    Clin Orthop Relat Res; 1997 Jan; (334):175-83. PubMed ID: 9005911
    [Abstract] [Full Text] [Related]

  • 3. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.
    van der Heide HJ, Rijnberg WJ, Van Sorge A, Van Kampen A, Schreurs BW.
    Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398
    [Abstract] [Full Text] [Related]

  • 4. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up.
    Grohs JG, Schmidt M, Wanivenhaus A.
    Acta Orthop; 2007 Feb; 78(1):95-8. PubMed ID: 17453399
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The incidence of heterotopic ossification after cementless total hip arthroplasty.
    Higo T, Mawatari M, Shigematsu M, Hotokebuchi T.
    J Arthroplasty; 2006 Sep; 21(6):852-6. PubMed ID: 16950038
    [Abstract] [Full Text] [Related]

  • 7. Heterotopic bone formation in total hip arthroplasty: predisposing factors, classification and the significance for clinical outcome.
    Schara K, Herman S.
    Acta Chir Orthop Traumatol Cech; 2001 Sep; 68(2):105-8. PubMed ID: 11706718
    [Abstract] [Full Text] [Related]

  • 8. Clinical significance of the heterotopic ossification after total hip arthroplasty.
    Kocic M, Lazovic M, Mitkovic M, Djokic B.
    Orthopedics; 2010 Jan; 33(1):16. PubMed ID: 20055344
    [Abstract] [Full Text] [Related]

  • 9. [Incidence of anterior intertrochanteric ossifications after total hip arthroplasty--a retrospective long-term follow-up study].
    Metzner G, Lindner B, Neumann D, Dorn U.
    Z Orthop Unfall; 2010 Mar; 148(2):174-9. PubMed ID: 20178081
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Risk factors associated with heterotopic ossifications in primary total hip arthroplasty].
    Handel M, Brettschneider J, Köck FX, Anders S, Perlick L, Sell S.
    Z Orthop Ihre Grenzgeb; 2004 Mar; 142(5):564-70. PubMed ID: 15472766
    [Abstract] [Full Text] [Related]

  • 12. [Prevention of periarticular ossification following endoprosthetic hip replacement using postoperative irradiation].
    Sauer R, Seegenschmiedt MH, Goldmann A, Beck H, Andreas P.
    Strahlenther Onkol; 1992 Feb; 168(2):89-99. PubMed ID: 1542851
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Heterotopic ossification in patients after total hip replacement.
    Stołtny T, Koczy B, Wawrzynek W, Miszczyk L.
    Ortop Traumatol Rehabil; 2007 Feb; 9(3):264-72. PubMed ID: 17721424
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Factors affecting the development of para-articular ossification in total hip replacement].
    Landor I, Vavrík P, Havelka S, Jahoda D.
    Acta Chir Orthop Traumatol Cech; 1993 Feb; 60(2):76-80. PubMed ID: 8342379
    [Abstract] [Full Text] [Related]

  • 18. Dose-dependent efficacy of diclofenac-cholestyramine on pain and periarticular ossifications after total hip arthroplasty: a double-blind, prospective, randomised trial.
    Handel M, Phillips O, Anders S, Köck FX, Sell S.
    Arch Orthop Trauma Surg; 2004 Sep; 124(7):483-5. PubMed ID: 15205987
    [Abstract] [Full Text] [Related]

  • 19. Prophylactic indomethacin for the prevention of heterotopic bone formation following total hip arthroplasty.
    Ritter MA, Sieber JM.
    Clin Orthop Relat Res; 1985 Jun; (196):217-25. PubMed ID: 3995821
    [Abstract] [Full Text] [Related]

  • 20. [Indomethacin in the prevention of para-articular ossification following total hip endoprosthesis].
    Hochheim B, Wünsche F.
    Beitr Orthop Traumatol; 1990 Jun; 37(6):330-4. PubMed ID: 2117436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.